C. Van Guldener et al., Carotid artery stiffness in patients with end-stage renal disease: no effect of long-term homocysteine-lowering therapy, CLIN NEPHR, 53(1), 2000, pp. 33-41
Background: The excess of cardiovascular disease in end-stage renal disease
(ESRD) patients is unexplained, but could relate to altered intrinsic vasc
ular wall properties, such as increased arterial stiffness, which could be
mediated by hyperhomocysteinemia. We investigated potential determinants of
carotid artery stiffness in ESRD patients and the effect of long-term homo
cysteine-lowering treatment. Patients and methods: Fifty-four patients on m
aintenance dialysis treatment were studied at baseline. Fourty-one patients
completed the treatment protocol, which consisted of a 12-week treatment w
ith folic acid 5 mg daily with or without betaine 4 g per day, and of 1 or
5 mg of folic acid thereafter for 40 weeks. Both phases were randomized. Co
mpliance and distensibility coefficients (CC and DC) and the stiffness inde
x (beta) of the common carotid artery were determined at baseline and after
52 weeks of treatment using a non-invasive vessel wall movement detector s
ystem. Results: At baseline, plasma total homocysteine was elevated (44.1 /- 33.7 mu mol/l), but showed no relationship with CC, DC or beta. Age and
mean arterial pressure (MAP) were the only independent determinants of CC a
nd DC, whereas beta was associated with age only. Plasma homocysteine showe
d a sustained decrease after therapy (20.7 +/- 9.0 mu mol/l at week 52). No
significant changes occurred in CC (from 0.59 +/- 0.21 to 0.60 +/- 0.22 mm
(2)/kPa; p = 0.47), in DC (from 14.9 +/- 6.1 to 15.3 +/- 6.2 10(-3)/kPa; p
= 0.55), or in beta (from 10.9 +/- 4.7 to 11.2 +/- 4.4; p = 0.64). No indep
endent determinants were detected for the change in CC, whereas the change
in DC was inversely related to the change in MAP (stand. r = -0.58; p < 0.0
002). The decrease in MAP after therapy was significant (p = 0.003) and was
related to the dialysis mode (p = 0.003) and smoking status (p = 0.02). Co
nclusion: Folic acid treatment of hyperhomocysteinemia has no major effect
on carotid artery stiffness in chronic dialysis patients. The results do, h
owever, emphasize the importance of tight blood pressure control in these p
atients.